Boston Scientific Corp
BSXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Boston Scientific Corp Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 1, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| EQUITEC PROPRIETARY MARKETS, LLC | 2026-03-31 | 11,100 | $697K | SEC filing |
| Winslow Capital Management, LLC | 2026-03-31 | 4,708 | $295K | SEC filing |
| Marex Group plc | 2026-03-31 | 6,310 | $396K | SEC filing |
| Nemes Rush Group LLC | 2026-03-31 | 17,875 | $1.12M | SEC filing |
| FIRST TRUST ADVISORS LP | 2026-03-31 | 184,386 | $11.6M | SEC filing |
| Redhawk Wealth Advisors, Inc. | 2026-03-31 | 3,765 | $236K | SEC filing |
| FINANCIAL CONSULATE, INC | 2026-03-31 | 288 | $18.1K | SEC filing |
| ABN AMRO Bank N.V. | 2026-03-31 | 438,340 | $27.7M | SEC filing |
| Alteri Wealth LLC | 2026-03-31 | 8,909 | $559K | SEC filing |
| IMA Advisory Services, Inc. | 2026-03-31 | 20,484 | $1.29M | SEC filing |
| OCCUDO QUANTITATIVE STRATEGIES LP | 2026-03-31 | 153,038 | $8.82M | SEC filing |
| EARNED WEALTH ADVISORS, LLC | 2026-03-31 | 5,351 | $336K | SEC filing |
| TD Capital Management LLC | 2026-03-31 | 121 | $7.59K | SEC filing |
| Westside Investment Management, Inc. | 2026-03-31 | 1,336 | $83.9K | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 393,586 | $24.7M | SEC filing |
| Argent Trust Co | 2026-03-31 | 15,336 | $962K | SEC filing |
| HARBOR INVESTMENT ADVISORY, LLC | 2026-03-31 | 2,619 | $164K | SEC filing |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 2026-03-31 | 1,078,109 | $67.7M | SEC filing |
| HUB Investment Partners, LLC | 2026-03-31 | 5,716 | $359K | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 3,611,020 | $227M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Boston Scientific Corp's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-02 · Mahoney Michael F: Larger than all 24 other insider sales of Common Stock on file. SEC filing
- 2025-06-02 · Mahoney Michael F: Larger than 22 of the 24 other insider sales of Common Stock on file. SEC filing
- 2025-05-01 · Mahoney Michael F: Larger than 23 of the 24 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-20 | Habiger David C · Director | Common Stock | P — Open market or private purchase | +2,250 | 55.92 | SEC filing |
| 2026-05-20 | Pegus Cheryl · Director | Common Stock | P — Open market or private purchase | +1,770 | 56.49 | SEC filing |
| 2026-05-20 | LUDWIG EDWARD J · Director | Common Stock | P — Open market or private purchase | +3,580 | 56.68 | SEC filing |
| 2026-05-19 | Habiger David C · Director | Common Stock | P — Open market or private purchase | +2,200 | 56.95 | SEC filing |
| 2026-02-02 | Mahoney Michael F · Chairman, President & CEO | Common Stock | S — Open market or private sale | −1,200 | 94.06 | SEC filing |
| 2026-02-02 | Mahoney Michael F · Chairman, President & CEO | Common Stock | S — Open market or private sale | −159,701 | 93.49 | SEC filing |
| 2025-12-01 | Butcher Arthur C · EVP& Grp Pres, MedSurg & APAC | Common Stock | S — Open market or private sale | −17,313 | 101.55 | SEC filing |
| 2025-11-06 | Zane Ellen M · Director | Common Stock | S — Open market or private sale | −12,891 | 98.28 | SEC filing |
Showing 8 of 14 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-28 | Mahoney Michael F · Chairman, President & CEO | Common Stock | G — Bona fide gift | −386,755 | SEC filing |
| 2026-05-07 | Morano Susan E · Director | Common Stock | A — Grant, award, or other acquisition | +1,281 | SEC filing |
| 2026-05-07 | Zane Ellen M · Director | Common Stock | A — Grant, award, or other acquisition | +3,800 | SEC filing |
| 2026-05-07 | Morano Susan E · Director | Common Stock | A — Grant, award, or other acquisition | +3,800 | SEC filing |
| 2026-05-07 | Weber Christophe Pierre · Director | Common Stock | A — Grant, award, or other acquisition | +1,767 | SEC filing |
| 2026-05-07 | WICHMANN DAVID S · Director | Common Stock | A — Grant, award, or other acquisition | +3,800 | SEC filing |
| 2026-05-07 | Smith Cathy R · Director | Deferred Stock Units | A — Grant, award, or other acquisition | +3,800 | SEC filing |
| 2026-05-07 | LUDWIG EDWARD J · Director | Common Stock | A — Grant, award, or other acquisition | +3,800 | SEC filing |
Showing 8 of 38 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-19 | Butcher Arthur C · EVP& Grp Pres, MedSurg & APAC | Common Stock | I — Discretionary transaction | +6,851 | SEC filing |
| 2025-10-29 | Zane Ellen M · Director | Common Stock | J — Other acquisition or disposition | +12,891 | SEC filing |
Showing 2 of 2 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.